Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleFEATURED ARTICLE OF THE MONTH
Open Access

First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer

Matthew R. Griffiths, David A. Pattison, Melissa Latter, Kevin Kuan, Stephen Taylor, William Tieu, Thomas Kryza, Danielle Meyrick, Boon Quan Lee, Aaron Hansen, Stephen E. Rose and Simon G. Puttick
Journal of Nuclear Medicine April 2024, 65 (4) 664; DOI: https://doi.org/10.2967/jnumed.123.267189
Matthew R. Griffiths
1Department of Nuclear Medicine and Specialist PET Services, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Pattison
1Department of Nuclear Medicine and Specialist PET Services, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melissa Latter
1Department of Nuclear Medicine and Specialist PET Services, Royal Brisbane and Women’s Hospital, Brisbane, Queensland, Australia;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Kuan
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Taylor
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Tieu
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Kryza
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle Meyrick
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boon Quan Lee
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Hansen
3Department of Medical Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen E. Rose
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon G. Puttick
2AdvanCell, Sydney, New South Wales, Australia; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Data supplements

  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (4)
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer
Matthew R. Griffiths, David A. Pattison, Melissa Latter, Kevin Kuan, Stephen Taylor, William Tieu, Thomas Kryza, Danielle Meyrick, Boon Quan Lee, Aaron Hansen, Stephen E. Rose, Simon G. Puttick
Journal of Nuclear Medicine Apr 2024, 65 (4) 664; DOI: 10.2967/jnumed.123.267189

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First-in-Human 212Pb-PSMA–Targeted α-Therapy SPECT/CT Imaging in a Patient with Metastatic Castration-Resistant Prostate Cancer
Matthew R. Griffiths, David A. Pattison, Melissa Latter, Kevin Kuan, Stephen Taylor, William Tieu, Thomas Kryza, Danielle Meyrick, Boon Quan Lee, Aaron Hansen, Stephen E. Rose, Simon G. Puttick
Journal of Nuclear Medicine Apr 2024, 65 (4) 664; DOI: 10.2967/jnumed.123.267189
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCE
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
  • SPECT Deserves RESPECT: The Potential of SPECT/CT to Optimize Patient Outcomes with Theranostics Therapy
  • Google Scholar

More in this TOC Section

  • MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
  • IL13Rα2-Targeting Antibodies for Immuno-PET in Solid Malignancies
  • Pilot Study of Nectin-4–Targeted PET Imaging Agent 68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human
Show more FEATURED ARTICLE OF THE MONTH

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire